HCC without cirrhosis is surprisingly common
A full 13% of patients diagnosed with hepatocellular carcinoma did not have underlying cirrhosis in a national sample of 1,500 veterans.
Eluxadoline scores in phase III trial for IBS
A first-in-class oral drug targeting diarrhea-predominant irritable bowel syndrome achieved its primary and secondary endpoints in a pair of large phase III trials presented at the annual Digestive Disease Week®.
Anti-TNFs safe in IBD pregnancy
Women with inflammatory bowel disease can safely continue monotherapy with azathioprine /6-mercaptopurine or antitumor necrosis–alpha agents during pregnancy to maintain remission, according to an analysis of 1,289 women and 1,039 live births.
Medicare to cover hep C screening
Medicare will cover screening for hepatitis C virus infection in high-risk beneficiaries, including a one-time screening for all beneficiaries born between 1946 and 1964.
ICD-10 delay: Proceed with caution, experts advise
When it comes to ICD-10 readiness, invest in low-cost, high-impact steps that will benefit the October 2015 switch to new code set, but will also improve the general health of the medical practice.